Interleukin-1β production in dysthymia before and after pharmacotherapy
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 46 (12) , 1649-1655
- https://doi.org/10.1016/s0006-3223(99)00211-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.Psychological Review, 1998
- Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionArchiv Fur Psychiatrie Und Nervenkrankheiten, 1997
- Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depressionJournal of Affective Disorders, 1995
- Cytokine Production and Serum Proteins in DepressionScandinavian Journal of Immunology, 1995
- The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymiaJournal of Affective Disorders, 1994
- Pharmacotherapy for ‘pure’ dysthymia: setraline vs. imipramine and placeboEuropean Neuropsychopharmacology, 1994
- Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophreniaPsychological Medicine, 1992
- Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody stainingPsychological Medicine, 1992
- Depression, immunocompetence, and prostaglandins of the E seriesPsychiatry Research, 1986
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979